Citi Has a New Warning for AppLovin Stock Investors - TradingView
π AppLovin shares fell 2.4% in premarket trading after Citi removed its 90-day catalyst watch.
π’ Citi warns that e-commerce customer adoption rates may be slower than previously expected.
π― The company will prioritize experienced advertisers before expanding to broader marketing segments.
π‘οΈ This strategy aims to improve models and brand strength while reducing churn risk from fixable issues.
π° Citi maintains a Buy rating with a $710 price target despite the slower near-term setup.
π AppLovin's approach is now viewed as more measured than during the Axon general availability phase.
Bullish Signals
- Citi maintains a Buy rating on AppLovin stock, indicating confidence in long-term value despite short-term headwinds.
- The firm keeps its $710 price target, suggesting significant upside potential remains for investors.
- AppLovin's strategic pivot to experienced advertisers could improve model quality and reduce customer churn risks.
Risk Factors
- Citi removed its 90-day catalyst watch, signaling a reduction in expected near-term growth momentum.
- The bank warns that e-commerce customer adoption is likely to proceed slower than previously forecasted.
- AppLovin must wait to expand into broader marketing segments until it has solidified its position with experienced advertisers.
Full Analysis
Citi removed its 90-day catalyst watch on AppLovin (APP) following premarket trading data showing shares down 2.4%. The bank adjusted its outlook, noting that the pace of e-commerce customer adoption is likely to be slower than previously anticipated.
While Citi maintains a Buy rating and a $710 price target, signaling continued belief in long-term upside, the firm expects near-term client growth to pause. AppLovin plans to focus on experienced advertisers first before gradually expanding into broader marketing segments.
This measured strategy aims to strengthen brand positioning and refine models while mitigating churn risks associated with less mature customers. The shift reflects a more cautious approach compared to the rapid expansion seen after Axon reached general availability.